An experimental drug shows promise in the treatment of the immune-system disorders multiple sclerosis and Crohn's disease. Studies in the New England Journal of Medicine suggest the drug's approach may be effective against a wide-range of immune disorders. NPR's Richard Knox reports.
Copyright 2003 NPR